BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9731137)

  • 1. Waiting list lengths show no signs of abating.
    Heywood Jones I
    Nurs Times; 1998 Jun 24-30; 94(25):19. PubMed ID: 9731137
    [No Abstract]   [Full Text] [Related]  

  • 2. No quick fix for the NHS.
    Coombes R
    BMJ; 2007 Jan; 334(7585):124-5. PubMed ID: 17235090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of private sector in United Kingdom healthcare system.
    Doyle Y; Bull A
    BMJ; 2000 Sep; 321(7260):563-5. PubMed ID: 10968825
    [No Abstract]   [Full Text] [Related]  

  • 4. Where are all the patients?
    Moore A
    Health Serv J; 2008 Sep; ():12-3. PubMed ID: 18833605
    [No Abstract]   [Full Text] [Related]  

  • 5. CMA's direction on the public-private interface.
    CMAJ; 2006 Oct; 175(9):1047. PubMed ID: 17060648
    [No Abstract]   [Full Text] [Related]  

  • 6. Private care. Putting on the Ritz.
    Jackman J
    Health Serv J; 1995 Nov; 105(5480):27-9. PubMed ID: 10153651
    [No Abstract]   [Full Text] [Related]  

  • 7. Are waiting lists becoming "the tail that wags the dog"?
    Chant AD
    Health Serv Manage; 1991 Oct; 87(5):228-9. PubMed ID: 10114968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Private practice. Author is lucky that his waiting list can be managed quickly.
    McGregor JC
    BMJ; 1996 Nov; 313(7069):1401. PubMed ID: 8956724
    [No Abstract]   [Full Text] [Related]  

  • 9. Some cancer waits and pressure on elective waiting times are caused by lack of money, MPs hear.
    Limb M
    BMJ; 2014 Nov; 349():g6809. PubMed ID: 25395489
    [No Abstract]   [Full Text] [Related]  

  • 10. Elasticity estimates from a dynamic model of interrelated demands for private and public acute health care.
    McAvinchey ID; Yannopoulos A
    J Health Econ; 1993 Jul; 12(2):171-86. PubMed ID: 10127775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Private health care in Canada.
    Curry K
    Public Health Rep; 1997; 112(6):445-6. PubMed ID: 10822469
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer services: it's make or break for waiting-list targets.
    Hobson S
    Health Serv J; 2004 May; 114(5905):10-1. PubMed ID: 15237542
    [No Abstract]   [Full Text] [Related]  

  • 13. How much does it cost to cut NHS waiting lists by calling in the private sector?
    Lancet; 1985 Feb; 1(8424):354. PubMed ID: 2857415
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgery waiting list targets remove choice and penalise services.
    Nazarko L
    Nurs Times; 2010 Jan 26-Feb 1; 106(3):9. PubMed ID: 20192041
    [No Abstract]   [Full Text] [Related]  

  • 15. Waiting in vain.
    Laurent C
    Nurs Times; 1991 Feb 27-Mar 5; 87(9):18. PubMed ID: 2000291
    [No Abstract]   [Full Text] [Related]  

  • 16. NHS waiting times could rise if private patient funds limit ditched.
    Dean E; Kendall-Raynor P
    Nurs Stand; 2011 Sep 7-13; 26(1):6. PubMed ID: 21977736
    [No Abstract]   [Full Text] [Related]  

  • 17. Top-up payments in cancer care.
    Sikora K; James N
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):1-5. PubMed ID: 19038536
    [No Abstract]   [Full Text] [Related]  

  • 18. Data briefing. First wave ISTCs: what do we know?
    Appleby J
    Health Serv J; 2007 Dec; 117(6085):23. PubMed ID: 18220216
    [No Abstract]   [Full Text] [Related]  

  • 19. Homa homes in on waiting lists. Interview by Anne Gulland.
    Homa P
    Nurs Times; 1998 May 27-Jun 2; 94(21):15. PubMed ID: 9668846
    [No Abstract]   [Full Text] [Related]  

  • 20. The two tier syndrome behind waiting lists. Government benefits from current system.
    Hockey MS
    BMJ; 2001 Feb; 322(7283):428; author reply 428-9. PubMed ID: 11179186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.